Understanding how cells recognize and degrade faulty mRNAs
Mechanisms of Translational Surveillance
This study is looking at how our cells find and get rid of faulty messages that can cause inherited diseases, and it's for anyone interested in understanding more about the genetic issues behind these conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Santa Cruz NIH-funded |
| Lab location | 1 site (Santa Cruz, United States) |
| Project ID | NIH-10897040 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which cells identify and eliminate mRNAs that contain early stop codons, which can lead to inherited diseases. The project aims to dissect the biochemical processes involved in Nonsense-Mediated mRNA Decay (NMD), focusing on how specific proteins and ribosomes interact to trigger the decay of these faulty mRNAs. By using advanced techniques, including CRISPR, the researchers will explore the roles of various factors in this critical cellular process, which could enhance our understanding of genetic diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic conditions linked to mutations that introduce early stop codons.
Not a fit: Patients whose conditions are not related to mRNA decay or early stop codon mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating genetic disorders caused by premature stop codons.
How similar studies have performed: Previous research has shown promising results in understanding mRNA decay mechanisms, but this specific approach using CRISPR is relatively novel.
Where this research is happening
Santa Cruz, United States
- University of California Santa Cruz — Santa Cruz, United States (Active)
Researchers
- Principal investigator: Arribere, Joshua — University of California Santa Cruz
- Study coordinator: Arribere, Joshua
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.